Novartis Ag (NVSEF) Gross Profit (2009 - 2025)

Novartis Ag has disclosed Gross Profit across 15 years of filings, most recently posting $11.5 billion for Q2 2025.

• Gross Profit for Q2 2025 came in at $11.5 billion, up 18.71% year-over-year; the trailing twelve-month figure through Jun 2025 was $56.4 billion (down 98.88% YoY), and the FY2025 annual result was $43.0 billion, up 10.49% from the prior year.
• Gross Profit came in at $11.5 billion for Q2 2025 at Novartis Ag, down from $18.7 billion in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $5000.0 billion in Q1 2023 to a low of -$1000.0 billion in Q4 2022.
• The 5-year median for Gross Profit is $8.9 billion (2022), against an average of $362.4 billion.
• Peak annual rise in Gross Profit reached 99509494.88% in 2022, while the deepest fall reached 7142957.14% in 2022.
• Novartis Ag's Gross Profit stood at $14.0 million in 2021, then sank by 7142957.14% to -$1000.0 billion in 2022, then jumped by 101.65% to $16.5 billion in 2023, then increased by 13.76% to $18.7 billion in 2024, then tumbled by 38.5% to $11.5 billion in 2025.
• The last three Gross Profit figures came in at $11.5 billion (Q2 2025), $18.7 billion (Q4 2024), and $9.7 billion (Q2 2024), per Business Quant data.